Ingersoll Rand Names Scott Watson as Leader for Life Science Technologies Platform
Ingersoll Rand has appointed Scott Watson, former Chief Operating Officer of ILC Dover, as the Senior Vice President and General Manager of its Life Science Technologies platform. The appointment is effective immediately, succeeding Corey Walker. Scott will oversee global strategy, operations, and new product development, and from January 2025, he will manage the legacy Ingersoll Rand medical business. Known for his operational expertise and strategic leadership, Scott has a strong track record in driving growth and operational excellence at ILC Dover.
Ingersoll Rand's CEO, Vicente Reynal, expressed confidence in Scott's ability to continue the company's success, highlighting his extensive experience in revenue generation and operational management. Scott holds advanced degrees from Northwestern University and Ohio University, emphasizing his strong academic background in business and engineering management.
- Scott Watson's appointment as Senior Vice President and General Manager brings decades of experience in operational and financial management.
- Scott has a proven track record in driving revenue and operational excellence at ILC Dover.
- His appointment is part of a thoughtful succession plan for seamless leadership transition.
- Scott's expertise in business functions like operations, supply chain, and product development is expected to further grow the life sciences platform.
- Corey Walker, the previous leader of the Life Science Technologies platform, has left the company, indicating potential instability in senior leadership.
- As Chief Operating Officer of ILC Dover, Scott Watson’s track record and operational expertise positions Ingersoll Rand for the next level of growth within life sciences
- Thoughtful succession plan positions company for seamless leadership transition
DAVIDSON, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, today announced Scott Watson, former chief operating officer of ILC Dover (“ILC”), to serve as the senior vice president and general manager of the Life Science Technologies platform, effective immediately. He succeeds Corey Walker, who left the company to pursue an external opportunity.
Scott is responsible for delivering ILC’s global strategy across commercial, operations, and new product development activities, and as of January 1, 2025, leadership over the legacy Ingersoll Rand medical business.
As Chief Operating Officer for ILC, the world-leader in the design and production of highly innovative solutions across life science end markets, Scott was responsible for the day-to-day strategy and execution of the company’s global operations, end-to-end supply chain, and manufacturing processes which led to the company’s operational and financial strength.
His experience and strong discipline across business functions (operations, supply chain, and product development) and execution of M&A makes him well-suited to further grow and develop the life sciences platform.
“Scott brings decades of experience in driving revenue and operational excellence, and has been instrumental in ILC Dover’s success,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “I am confident Scott will lead the business with the level of depth and accountability needed to ensure success.”
Scott holds a Master of Business Administration from Northwestern University’s Kellogg School of Management, a Master of Engineering Management from Northwestern University’s McCormick School of Engineering and Applied Sciences, and a Bachelor of Business Administration from Ohio University.
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Ingersoll Rand Inc.’s (the “Company” or “Ingersoll Rand”) expectations regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.
These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to natural disaster, catastrophe, global pandemics (including COVID-19), geopolitical tensions, cyber events or other events outside of our control; (2) unexpected costs, charges or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.
Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or development, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.
About Ingersoll Rand Inc.
Ingersoll Rand Inc. (NYSE:IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency. For more information, visit www.IRCO.com.
Contacts:
Investor Relations:
Matthew.Fort@irco.com
Media:
Sara.Hassell@irco.com
FAQ
Who has Ingersoll Rand named as the leader for its Life Science Technologies platform?
When did Scott Watson's appointment at Ingersoll Rand become effective?
What is Scott Watson's background before joining Ingersoll Rand?
What responsibilities will Scott Watson have at Ingersoll Rand?
What are the qualifications of Scott Watson?
